Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Trichuris muris ACR-16-like nicotinic acetylcholine receptor (nAChR) is a ligand-gated ion channel essential for the neuromuscular function of the mouse whipworm, a common laboratory model for the human parasite Trichuris trichiura (Hurst et al., 2014, PLOS Negl Trop Dis). This receptor belongs to the alpha-7-like clade of nematode nAChRs and is primarily expressed in the muscle cells and neurons of the parasite, where it facilitates excitatory neurotransmission (Abongwa et al., 2017, Molecules). It is recognized as a major therapeutic target because it is the specific site of action for the anthelmintic drug oxantel, which serves as a potent agonist (Hurst et al., 2014). Upon binding, oxantel triggers a persistent opening of the ion channel, leading to an influx of cations, prolonged depolarization, and subsequent spastic paralysis of the worm (Callahan et al., 2018, Int J Parasitol Drugs Drug Resist). This mechanism allows for the effective clearance of the parasite from the host's intestinal tract, making the receptor a focal point for developing treatments for trichuriasis, a neglected tropical disease affecting millions (World Health Organization).
Agonist-induced activation of the receptor leads to an influx of cations (Na+ and Ca2+), causing persistent depolarization of the muscle cell membrane. This results in spastic paralysis of the parasite, preventing it from maintaining its position in the host's intestine and leading to its expulsion (Hurst et al., 2014; Abongwa et al., 2017).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trichuris muris ACR-16-like nicotinic acetylcholine receptor (Tm-ACR-16).